Three-Year NHS Study Shows Blood Test Reduces Stage IV Cancer Diagnoses
The Galleri blood test demonstrated a four-fold increase in cancer detection rates and substantial reduction in stage IV cancer diagnoses in 142,000 participants.
Latest Articles
Editor's Top Picks
What Clinical Lab Leaders Predict for 2026
AI, new diagnostics, and shifting care delivery models are among the clinical laboratory predictions for 2026.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
Thermo Fisher Introduces Sequential Protein/DNA/RNA Extraction Kit
Thermo Fisher Scientific has launched a kit enabling sequential extraction of protein, DNA, and RNA from a single sample, supporting multi-omics cancer research and downstream mass spectrometry and sequencing applications.
Equipment & Supply Spotlight
New England Biolabs Releases Magnetic Bead Kit for Cell-Free DNA Extraction
The automation-compatible system works with plasma, serum, urine and cerebrospinal fluid samples from 1 ml to 4 ml input volumes.
News, Know-How & Standards
Disease Detection & Understanding
Trinity Biotech Receives Final Regulatory Approval for HIV Test Manufacturing Model
Trinity Biotech has received final regulatory approval to transition upstream manufacturing of its Uni-Gold HIV rapid test to an offshore platform, a move expected to improve scalability and margins.
